Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry

• Main Authors: Esmé Kamphuis (Author), Celeste M. Boesjes (Author), Laura Loman (Author), Marijke Kamsteeg (Author), Inge Haeck (Author), Anneke M.T. van Lynden-van Nes (Author), Klaziena Politiek (Author), Liana F. van der Gang (Author), Marlies de Graaf (Author), Marjolein S. de Bruin-Weller (Author), Marie L.A. Schuttelaar (Author)
• Format: Knjiga
• Izdano: Medical Journals Sweden, 2024-02-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Limited daily practice data on the effect of abrocitinib in patients with atopic dermatitis are available. The aim of this multicentre prospective study is to evaluate the effectiveness and safety of abrocitinib in patients with atopic dermatitis treated in daily practice. In a subgroup, the effecti...